DPP-4 inhibitors, also known as gliptins, are oral diabetic medications approved by the Food and Drug Administration (FDA) to treat type 2 diabetes mellitus in adults. It works by blocking the action of the DPP-4 enzyme responsible for destroying the incretin hormone. The incretin hormone produces insulin whenever required and can reduce the glucose level produced by the liver when not needed.